(Press-News.org) Over the last decade, poisonings and deaths linked to the use of local anesthetics have decreased. Even so, poisonings from one commonly used anesthetic, lidocaine, have increased in the United States, according to two new studies from the University of Illinois Chicago.
By analyzing data from reports to national Poison Control Centers and to the Food and Drug Administration from 2010 to 2020, UIC researchers found total reports of poisonings fell 50% in that period. But poisonings from lidocaine increased more than 50% in less than half that time, between 2016 and 2020. The findings are published in Regional Anesthesia & Pain Medicine and the British Journal of Anesthesia.
Local anesthetics, including lidocaine, are widely used in medical care to manage pain before, during and after surgical procedures. General anesthesia acts everywhere in the body and puts patients in a sleep-like state. Local anesthesia controls pain and immobilizes a specific region of the body while a patient remains conscious.
Local anesthetics numb an area of the body by blocking nerve signals, explained Dr. Michael Fettiplace, an assistant professor in the anesthesiology department in the College of Medicine. “They’re incredibly useful drugs, and second to opioids, local anesthetics are the No. 2 pain control tool that we have.”
Today, lidocaine is “undoubtedly the most frequently used local anesthetic,” Fettiplace said. Its applications are numerous: to numb an area of skin before getting stitches, to prevent arrhythmias and to coat the throat in preparation for an upper endoscopy, for example. Lidocaine is also available over the counter in topical patches and creams marketed to soothe sore backs and hemorrhoid pain, for instance.
Like all drugs, lidocaine and other local anesthetics carry both benefits and risks. After administration, blood vessels absorb and transport local anesthetics to the liver, where they are processed and detoxified. But if a patient gets too much of the drug, extreme blocking of nerve channels can progress to seizures, lethal arrythmias or cardiac arrest, a phenomenon known as local anesthetic systemic toxicity.
In 1998, UIC anesthesiologist and professor Dr. Guy Weinberg discovered that an intravenous treatment called lipid emulsion could treat the issue. “This was a revolution in the anesthesia field,” Fettiplace said. “All of a sudden, patients who arrested and died of local anesthetic systemic toxicity now had a treatment which, in many anecdotal cases, rapidly alleviated the toxic symptoms and prevented deaths.”
In 2010, several professional societies in the United States and the United Kingdom developed recommendations to identify, prevent and treat poisonings from local anesthetics, with the use of lipid emulsions at their center. A decade later, Fettiplace and his colleagues set out to see how these advisories have affected reported poisonings and deaths associated with the drugs.
The researchers analyzed reports submitted to the National Poison Data System, the database of all 53 Poison Control Centers in the United States, and to the FDA Adverse Event Reporting System, a database of similar reports collected by the U.S. Food and Drug Administration. Through their analyses, they found fatalities mostly occur when the lidocaine is delivered either by vein or to coat the throat, and almost always when given at extremely high doses, sometimes as much as four times the upper limit, Fettiplace said.
This issue is compounded by the availability of high-dose delivery methods and the potential for accidental overdose by emergency medical personnel. The authors suggest that enhanced education and updated recommendations could mitigate these risks, as recommendations have been successful in decreasing overall poisonings and deaths from anesthesia.
The local anesthesia advisories and the surrounding changes in the science had an instrumental impact, Fettiplace said. “The data indicates that there’s been a reduction either in the number of events or the number of adverse outcomes by about 50% over the past 15 years,” he said.
Still, the rise in lidocaine-related poisonings signals that current safeguards may not be enough. Fettiplace and his colleagues believe that new, more targeted recommendations could further reduce harm.
“We think if we have updated advisories that are more targeted to some of the problems that we see occurring now, those may have impacts 10 years down the line,” he said.
In addition to Fettiplace and Weinberg, UIC authors on the studies include Heather Nixon, Alexandra Barabanova and Christopher Chiang.
END
Lidocaine poisonings rise despite overall drop in local anesthetic toxicity
2025-10-06
ELSE PRESS RELEASES FROM THIS DATE:
Politics follow you on the road
2025-10-06
Nobody wants to admit that a lowly bumper sticker can influence their behavior.
But researchers at the University of Cincinnati found that drivers were far more likely to honk after being cut off by a vehicle bearing a political bumper sticker, particularly one for the opposing political party.
“Bumper stickers are a meaningful way in which partisan divides are reinforced in everyday life,” UC researchers concluded. “They have tangible impacts on road safety. Partisan bumper stickers may be mundane, but they are not trivial.”
For a study published in the journal Frontiers in Political Science, UC Assistant ...
Scientists blaze new path to fighting viral diseases
2025-10-06
JUPITER, Fla. — In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.
In the process, the team devised a powerful new platform for finding medicines to fight many types of infectious diseases.
Writing in the Journal of the American Chemical Society, in an online article posted on Monday, Oct. 6, 2025, the scientists said they began by seeking ...
The mouse eye as a window to spotting systemic disease
2025-10-06
A new method of taking microscopic images of a live mouse’s retina through the eye allows to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable than previous methods and promises to advance research on and treatment of vision-related diseases.
Diabetic retinopathy, a form of diabetic eye disease, is one of the leading causes of blindness around the globe. “It’s understood that vision is lost due to damage to the blood vessels in the retina, but recent research has identified that abnormalities in neurons and immune cells begin prior to vascular damage,” says Kobe ...
AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs
2025-10-06
Rockville, MD. (October 6, 2025) – The 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship will convene an extraordinary roster of world-renowned scientists, entrepreneurs, investors, and patient advocates on October 24, 2025, at the National Press Club in Washington, D.C.
This is a signature annual gathering where the leaders driving the future of oncology come together under one roof to challenge the status quo, reveal bold ideas, share insights, and spark collaborations that shape what’s next in cancer research ...
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
2025-10-06
Key takeaways
Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with healing.
Funded entirely by federal and state grants, the researchers developed a drug to block this protein and promote tissue regeneration.
The FDA has now granted approval to begin Phase I clinical trials of the first-in-class drug for tissue repair, called AD-NP1, in humans.
The body’s tissues can get injured in many ways, but while some injuries ...
Exploring the therapeutic potential of cannabidiol for Alzheimer's
2025-10-06
Neuroinflammation damages neurons and can contribute to diseases like Alzheimer’s. Cannabidiol (CBD) has anti-inflammatory properties, which suggests that it could combat neuroinflammation in Alzheimer’s. In a new eNeuro paper, Babak Baban and colleagues, from Augusta University, explored whether CBD can be leveraged as an antiinflammatory treatment in an established Alzheimer’s disease mouse model.
The researchers assessed two distinct mechanisms for shaping immune responses and regulating neuroinflammation ...
We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say
2025-10-06
Images
Spirals of solar wind can spin off larger solar eruptions and disrupt Earth's magnetic field, yet they are too difficult to detect with our current single-location warning system, according to a new study from the University of Michigan.
But a constellation of spacecraft, including one that sails on sunlight, could help find the tornado-like features in time to protect equipment on Earth and in orbit.
The study results come from computer simulations of a massive cloud of plasma erupting from the sun and moving through the solar system. Because the simulation covers features that span ...
Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results
2025-10-06
The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously discussed by experts. The first results of the ASAP study (ASAP standing for “as soon as possible”), published in 2024, have already attracted considerable attention [2]. ASAP questions existing treatment standards for AML and was the first randomized controlled trial to compare remission induction with salvage chemotherapy prior to allo-HSCT – which represents ...
Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity
2025-10-06
In a recent study published in Cell Metabolism, a collaborative research team led by Chen-Yu Zhang, Xi Chen, and Di-Jun Chen from Nanjing University, together with Tao Zhang from Nanjing Medical University, reported groundbreaking findings in their paper entitled “Paternal exercise confers endurance capacity to offspring through sperm microRNAs.” This research provides the first evidence that sperm microRNAs act as carriers of epigenetic information, enabling the intergenerational transmission of paternal ...
Seeing double: Clever images open doors for brain research
2025-10-06
New artificial intelligence-generated images that appear to be one thing, but something else entirely when rotated, are helping scientists test the human mind.
The work by Johns Hopkins University perception researchers addresses a longstanding need for uniform stimuli to rigorously study how people mentally process visual information.
“These images are really important because we can use them to study all sorts of effects that scientists previously thought were nearly impossible to study in isolation—everything from size to animacy to emotion,” said ...